A_DT
protein_NN
of_IN
the_DT
AP-1_NN
family_NN
is_VBZ
a_DT
component_NN
of_IN
nuclear_JJ
factor_NN
of_IN
activated_VBN
T_NN
cells_NNS
._.

Nuclear_JJ
factor_NN
of_IN
activated_VBN
T_NN
cells_NNS
-LRB-_-LRB-
NF-AT_NN
-RRB-_-RRB-
is_VBZ
a_DT
transcriptional_JJ
activator_NN
involved_VBN
in_IN
the_DT
induction_NN
of_IN
IL-2_NN
gene_NN
expression_NN
._.

The_DT
response_NN
element_NN
for_IN
NF-AT_NN
is_VBZ
a_DT
sequence_NN
localized_JJ
between_IN
-285_NNP
\/_:
-254_CD
in_IN
the_DT
IL-2_NN
regulatory_JJ
region_NN
._.

The_DT
composition_NN
of_IN
NF-AT_NN
protein_NN
is_VBZ
still_RB
not_RB
fully_RB
elucidated_VBN
._.

We_PRP
demonstrate_VBP
that_IN
,_,
in_IN
normal_JJ
human_JJ
T_NN
cells_NNS
,_,
an_DT
AP-1_NN
protein_NN
is_VBZ
a_DT
component_NN
of_IN
the_DT
NF-AT_NN
protein_NN
complex_NN
._.

This_DT
was_VBD
evidenced_VBN
by_IN
the_DT
ability_NN
of_IN
the_DT
AP-1_NN
site_NN
to_TO
compete_VB
with_IN
the_DT
NF-AT_NN
site_NN
for_IN
binding_NN
to_TO
NF-AT_NN
and_CC
by_IN
the_DT
capacity_NN
of_IN
immobilized_VBN
anti-Jun_JJ
and_CC
anti-Fos_JJ
antibodies_NNS
to_TO
deplete_VB
NF-AT-binding_JJ
activity_NN
from_IN
nuclear_JJ
extracts_NNS
of_IN
activated_VBN
T_NN
cells_NNS
._.

There_EX
was_VBD
no_DT
detectable_JJ
binding_NN
of_IN
in_FW
vitro_FW
translated_VBN
Jun\/Fos_NN
heterodimer_NN
-LRB-_-LRB-
AP-1_NN
-RRB-_-RRB-
to_TO
the_DT
NF-AT_NN
sequence_NN
,_,
and_CC
the_DT
NF-AT_NN
sequence_NN
was_VBD
unable_JJ
to_TO
inhibit_VB
the_DT
binding_NN
of_IN
Jun\/Fos_NN
to_TO
the_DT
AP-1_NN
sequence_NN
._.

The_DT
presence_NN
of_IN
an_DT
AP-1_NN
protein_NN
in_IN
the_DT
NF-AT_NN
protein_NN
complex_NN
may_MD
regulate_VB
NF-AT-binding_JJ
activity_NN
through_IN
protein-protein_JJ
interaction_NN
._.

